Advanced Cell Technology OneMedForum 2011
Advanced Cell Technology OneMedForum 2011
Last Updated on Thursday, 10 November 2011 10:28 Written by Administrator Thursday, 10 November 2011 10:28
Company Overview Advanced Cell Technology, Inc. (OTCBB:ACTC — News) is a biotechnology company that specializes in the development of cellular therapies for the treatment of rare and common diseases that impact millions of people worldwide. The company applies stem cell-based technologies and other proprietary methods in the area of regenerative medicine to bring patient-specific therapies from the lab to the bedside. The Company is in the final stages of moving toward the initiation of Phase I clinical trials for its Retinal Pigment Epithelial (RPE) program which addresses a number of retinal degenerative disorders. ACT has published positive data from animal studies for the RPE cell program — completed in collaboration with the Casey Eye Institute at Oregon Health and Science University (OHSU) — as well as recently announced promising results — also in collaboration with OHSU- from GLP Safety Studies and long-term efficacy studies for the RPE therapy. Currently ACT is finalizing preclinical studies for the bio-distribution of RPE and expects spiking studies to be finished in the second half of 2009. ACT expects to file the RPE program IND by the end of the year. Advanced Cell also has moved forward rapidly with it Hemangioblast (HG) platform. ACT has published positive data in the journal NATURE Methods for its HG cellular program for the treatment of blood and cardiovascular diseases. Additionally the company’s Myoblast program is an autologous adult stem cell …
Related Stem Cell Articles
Tags: 2011, Advanced, Cell, OneMedForum, Technology
BTW “The London Project” is not related to ACT.
But they do work with pfizer.
How long will it take for a treatment reaches clinics if most goes well?
Pete coffey of “The London Project” said in a newspaper, in 2015 repairing eyes will be standard. But they are going to start this year but Q4. Would be good they worked together.
I sold actc on yesterday and bought mmte and cwrn. made all my money back from actc’s fall.
Great presentation -
HaHa Feeed, Good to see you
feeed loves Dr, Lanza